[Federal Register Volume 80, Number 6 (Friday, January 9, 2015)]
[Notices]
[Pages 1417-1419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-00145]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 79 FR 32739-32740, dated June 7, 2014) is
amended to reflect the reorganization of the Global Immunization
Division within the Center for Global Health.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and the mission and function
statements for the Global Immunization Division (CWK) and insert the
following:
Global Immunization Division (CWK). The Global Immunization
Division (GID) protects the health of Americans and global citizens by
preventing disease, disability, and death worldwide from vaccine-
preventable diseases. In carrying out its mission, GID: (1) Provides
national leadership and coordination of the Center for Global Health
(CGH) efforts to eradicate polio; eliminate measles and rubella in
World Health Organization (WHO) regions; strengthens global
surveillance to prevent, detect, and respond to vaccine preventable
diseases; strengthens routine immunization programs; introduces new and
under-utilized vaccines; and promotes safe injection practices in
collaboration with international organizations and CDC Centers/
Institute/Offices (CIOs); (2) provides technical expertise to global
partners--WHO, United Nations International Children's Emergency Fund
(UNICEF), Global Alliance for Vaccine Immunization (GAVI), and the Bill
and Melinda Gates Foundation (BMGF)--involved in global immunization
activities and participates in international advisory group meetings on
immunization issues; (3) ensures provision of technical expertise on
evidence-based research, strategies, and policy at global and country
levels in collaboration with multilateral and bilateral partners; (4)
collaborates with other countries and administers grants to WHO, Pan
American Health Organization (PAHO), UNICEF, and other international
partners and advocacy groups as appropriate for the provision of
technical, programmatic, and laboratory support, and vaccine
procurement for initiatives to support global immunization targets; (5)
improves surveillance for polio, measles, rubella, and other vaccine
preventable diseases by working with individual countries and the WHO
regional offices to improve surveillance and to collaborate with groups
within and outside CDC to expand environmental surveillance; (6)
achieves global immunization targets by supporting the strengthening of
the implementation of national immunization policies; (7) strengthens
appropriate vaccination policy development and implementation,
identifies barriers to vaccine acceptance, and develops communication
strategies to promote vaccine uptake and disease reduction; (8)
develops strategies to improve the technical skills and problem-solving
abilities of program managers and health care workers in other
countries; (9) prepares immunization articles based on findings for
publication in international professional journals and for presentation
at international conferences; and (10) provides technical and
operational leadership for CDC's activities in support of the
initiatives.
Office of the Director (CWK1). (1) Provides leadership, management,
and oversight for all division activities including administrative,
budget, finance, research, workforce development, management and
operations; (2) assists leadership in the formulation and defense of
GID budget requests, and monitors and seeks strategies to mitigate
division risks; (3) provides coordination and oversight of the
division's personnel actions including liaison with CGH and CDC's human
resource office; (4) provides oversight for workforce planning,
recruitment, deployment, field staff support, professional development,
and monitoring and evaluation; (5) develops and promotes partnerships
with other organizations to support global immunization activities and
works closely with partners in academia; (6) liaises and coordinates
with other CDC offices engaged in global immunization activities; (7)
provides leadership and oversight for scientific and programmatic
activities related to the implementation of GID's objectives and
ensures that the research and economic portfolios are integrated across
the branches and with field activities; (8) identifies program policy
priorities through strategic planning and other processes as
appropriate; (9) clears all scientific publications from the division
working in close collaboration with management of GID; (10) provides
coordination of the division's communications activities including
liaison with other CDC communications offices and those of our partner
agencies; (11) represents CDC, CGH, and the division at global and
national meetings and other fora for global immunization activities;
(12) provides
[[Page 1418]]
oversight for all Embassy/International Cooperative Administrative
Supportive Services costs for the division's field staff; and (13)
works in close collaboration and interfaces with CGH and other CIOs,
global immunization partners, and other collaborating partners in
matters relating to program development and research.
Polio Eradication Branch (CWKB). (1) Achieves global polio
eradication in partnership with the Global Polio Eradication Initiative
(GPEI) and optimize polio investments toward future health goals; (2)
acts as CDC's lead for polio eradication activities in countries within
Africa in partnership with GPEI; (3) works with polio free regions to
strengthen their efforts to remain polio-free, particularly in the
areas of surveillance, outbreak preparedness, containment and legacy
planning; (4) improves surveillance for polio by working with
individual countries, WHO regional offices, and groups within and
outside CDC to expand environmental surveillance; (5) is prepared to
respond quickly to outbreaks of wild poliovirus and circulating
vaccine-derived polioviruses; (6) leads work in countries at high risk
for polio; (7) leads activities to achieve poliovirus containment by
the required deadlines; (8) oversees technical aspects of specific
polio activities funded by CDC; (9) prepares countries for
certification; (10) leads or collaborates in research to support polio
eradication goals; (11) identifies opportunities to leverage polio
eradication assets to promote sustainable improvements in routine
immunization systems, in collaboration with the Immunization Systems
Branch; (12) defines and ensures a sustainability legacy for the polio
eradication program in addition to polio eradication itself and
identifies opportunities to implement strategies toward this goal; (13)
coordinates with key partners within and outside CDC; (14) promotes the
National Stop Transmission of Polio (NSTOP)program; (15) develops
priorities for CDC's involvement in polio eradication research and
innovation activities; (16) collects and analyzes data on wild polio
virus and vaccine perceived polio virus incidence, surveillance
performance and immunization status based on acute flaccid paralysis
surveillance and supplemental immunization activities implementation
quality; (17) provides support to regional and country teams in
assessing risk of outbreaks of wild poliovirus and circulating vaccine-
derived polioviruses; responding to outbreaks; planning and
implementing mitigating activities to prevent outbreaks; improving
surveillance; and assisting in development of documentation to support
certification and containment; and (18) supports the completion of
global polio eradication through strengthening surveillance, innovation
and research.
Accelerated Disease Control and Vaccine Preventable Diseases
Surveillance Branch (CWKC). (1) Achieves accelerated disease control
goals for vaccine preventable diseases (VPD), with a high focus on
eliminating measles and rubella in WHO regions in partnership with the
Measles and Rubella Initiative (MRI), and strengthening global
surveillance to prevent, detect and respond to VPDs; (2) leads global
and regional measles elimination goals; (3) provides expert technical
input toward development, evaluation, and improvement of program
activities and strategies to mitigate risk and achieve global and
regional measles elimination goals; (4) monitors measles incidence and
risk through development and analysis of high quality surveillance data
and risk estimates, estimating burden of disease/death and verifying
elimination; (5) develops and maintains outbreak preparedness and
respond rapidly to outbreaks; (6) oversees the technical aspects of
measles activities funded by CDC; (7) leads global and regional rubella
control and elimination goals; (8) provides expert technical input to
countries on the development and implementation of national plans of
action for rubella vaccine introduction and the control and elimination
of rubella and congenital rubella syndrome; (9) leads activities of the
MRI, including participation on working groups, as appropriate; (10)
strengthens labs and lab networks to ensure appropriate and timely
specimen collection, testing, and result dissemination; (11) develops
and maintains outbreak control strategies, including developing
mathematical models to estimate the target age range for achieving
program goals; (12) provides technical support to reach global or
regional goals for control of targeted VPDs; (13) provides expert
technical input towards development, evaluation, and improvement of
program activities and strategies to mitigate risk and achieve global
and regional VDP control goals; (14) monitors prevalence, incidence and
risk through development and analysis of high quality surveillance data
and risk estimates, estimating burden of disease/death and verifying
elimination; (15) conducts research and evaluation to maximize the
cost-effectiveness of elimination and outbreak control strategies; (16)
oversees the technical aspects of targeted VPD activities funded by
CDC; (17) provides ongoing support for development, implementation,
quality, and use of VPD surveillance; (18) evaluates VPD surveillance
systems and improves the quality, analysis, and use of surveillance
data for program action and decision-making; (19) provides technical
assistance in establishing and maintaining surveillance for diseases
prevented by new or underutilized vaccines; (20) conducts research and
evaluation to maximize surveillance performance and cost-effectiveness;
and (21) leads innovative research and development to strengthen
surveillance and improve laboratory diagnosis.
Immunization Systems Branch (CWKD). (1) Achieves global
immunization targets by supporting the strengthening of the
implementation of national immunization policies; identifies strategies
to increase vaccine demand; promotes the appropriate introduction and
use of quality vaccines; and strengthens routine immunization program
delivery and equitable access to vaccines, while promoting synergies
through the child health agenda; (2) leads development and
implementation of effective communication strategies that address
issues related to vaccine demand and uptake; (3) identifies caregiver,
provider, and community determinants that affect vaccine demand, in
order to develop evidence-based strategies to remove barriers and
increase demand for immunization; (4) evaluates vaccine policy
development, implementation, and impact, and advocates for policies
demonstrated to support acceptance of vaccine; (5) accelerates progress
toward achieving the millennium development goals of mortality
reduction and disease prevention by advocating and promoting the
appropriate and equitable introduction of new and underutilized
vaccines; (6) builds evidence and rationale for vaccine introduction;
(7) secures WHO-prequalification; (8) provides technical and
programmatic assistance to countries to introduce new and underutilized
vaccines into their national immunization programs; (9) evaluates
effectiveness of introduction of new and underutilized vaccines in
terms of uptake, impact on existing immunization program function, and
potential impact on disease burden; (10) works with VPD Surveillance
Team and CDC subject matter experts to build country capacity for
future introduction of new and underutilized vaccines; (11)
[[Page 1419]]
leads inactive polio virus introduction to immunization systems in oral
polio virus using countries as mandated through the Immunization
Management Group of the Global Polio Eradication Initiative; improves
routine immunization systems globally (or improves access to and
utilization of vaccines globally through strengthening of routine
immunization systems); (12) develops, evaluates, and scales-up
evidence-based strategies to tackle inequities in access to and
delivery of vaccines; (13) develops evaluates, and scales-up
comprehensive and coordinated approaches to integrate immunization
services; (14) promotes innovation to improve routine immunization
program efficiencies and increase coverage and impact; (15) conducts
advocacy to national programs on the need to strengthen immunization
system abilities to monitor, assess and respond to issues related to
vaccine safety; and (16) conducts operational research to identify and
test interventions to improve the access and utilization of
immunization services and provide guidance on what areas are in need of
workforce capacity building activities.
Strategic Information and Workforce Development Branch (CWKE). (1)
Builds workforce, systems, and information capacity to effectively
deliver immunization services in selected countries; (2) provides
technical assistance and support, guidance, and advice on statistical
analysis and study design, data management, and data integrity to the
GID; (3) provides statistical expertise to support internal data
management needs of the division and field staff (standard setting for
record keeping, archiving, ensuring reproducibility of analyses); (4)
collaborates with branch and team level leadership and GID management
to ensure that statistical and methodological standards continue to
remain an integral part of planning, conduct, and review of science and
program within GID including with the context of the official clearance
process; (5) provides GID statistical representation on internal and
external committees and work groups and at relevant meetings,
workshops, and fora; (6) promotes capacity building for polio, other
VPDs and immunization functions in partnership with WHO and UNICEF
through recruiting, coordinating training of, and deploying STOP teams;
(7) promotes capacity building for polio, other VPDs and immunization
functions in partnership with WHO and UNICEF; (8) leads the development
of strong national immunization programs and systems through workforce
capacity development; (9) ensures recruitment for training and WHO
deployment for each STOP team; (10) creates and maintains strategic
partnerships and collaborations and provides technical assistance to
develop and evaluate sustainable programs aimed at increasing capacity
and effectiveness of workforce responsible for implementing
immunization programs; (11) conducts operational research to identify,
implement and evaluate interventions aimed at improving immunization
(or integrated public health) workforce effectiveness and contributes
to the scientific knowledge base regarding interventions aimed at
improving immunization workforce effectiveness; (12) leads
strengthening routine immunization systems as mandated through the
Immunization Management Group of the Global Polio Eradication
Initiative; and (13) leads the development of strong immunization
systems through improving quality, management, and use of immunization
data and providing specific technical skills for program evaluation to
include strategic information, informatics and information systems,
program evaluation, polio eradication and endgame strategy, and
operational research.
James D. Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-00145 Filed 1-8-15; 8:45 am]
BILLING CODE 4160-18-P